M&A Deal Summary

Kinetic Concepts Acquires Systagenix Wound Management

On October 28, 2013, Kinetic Concepts acquired medical products company Systagenix Wound Management from One Equity Partners for 485M USD

Acquisition Highlights
  • This is Kinetic Concepts’ 2nd transaction in the Medical Products sector.
  • This is Kinetic Concepts’ largest (disclosed) transaction.
  • This is Kinetic Concepts’ 1st transaction in the United Kingdom.
Investment Fate
  • Systagenix Wound Management was divested to a consortium of strategic buyers in 2014.

M&A Deal Summary

Date 2013-10-28
Target Systagenix Wound Management
Sector Medical Products
Buyer(s) Kinetic Concepts
Sellers(s) One Equity Partners
Deal Type Add-on Acquisition
Deal Value 485M USD

Target

Systagenix Wound Management

Gatwick, United Kingdom
Systagenix Wound Management Ltd. is a provider of advanced wound care market and develops, manufactures and markets products in approximately 50 countries worldwide.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kinetic Concepts

San Antonio, Texas, United States

Category Company
Founded 1976
Sector Medical Products
DESCRIPTION

Kinetic Concepts, Inc. is a developer and marketer of an innovative medical devices for advanced wound healing and therapeutic treatment systems that address skin breakdown, pulmonary complications, and circulation problems associated with patient immobility. KCI's medical devices and therapeutic systems include V.A.C.® Therapy Systems, as well as specialty beds, mattress replacement systems, wheelchair seating, and related devices. KCI serves hospitals, nursing homes, and home care settings both in the U.S. and abroad.


DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 2 of 2
Country (United Kingdom) 1 of 1
Year (2013) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-04-01 LifeCell

Branchburg, New Jersey, United States

LifeCell Corp. is a provider of applications in plastic and reconstructive surgeries and abdominal wall procedures.

Buy $170M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-09-03 Systagenix Wound Management

Gatwick, United Kingdom

Systagenix Wound Management Ltd. is a provider of advanced wound care market and develops, manufactures and markets products in approximately 50 countries worldwide.

Sell -

Seller(S) 1

SELLER

One Equity Partners

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

One Equity Partners (OEP) is a private equity firm that targets buyout and growth capital investments in North America, Europe, and Asia. OEP prefers to be the lead investor and typically commits $30 to $300 million per transaction. Sectors of interest include industrial products/services, consumer, retail, chemicals, media, communications, and healthcare. One Equity Partners was formed in 2001 and spun out of JP Morgan Chase in 2015. One Equity Partners is based in New York City.


DEAL STATS #
Overall 20 of 63
Sector (Medical Products) 2 of 4
Type (Add-on Acquisition) 15 of 36
Country (United Kingdom) 1 of 2
Year (2013) 3 of 4
Size (of disclosed) 17 of 20
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-10-07 Chemlogics Group

Paso Roble, California, United States

Chemlogics provides the energy sector with specialty chemicals used in the extraction and production of oil and gas.

Sell $1.3B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-13 PeroxyChem

Philadelphia, Pennsylvania, United States

PeroxyChem LLC is a provider in peroxygen and adjacent chemistries with facilities in North America, Europe, and Asia. PeroxyChem manufactures high-quality products and innovative applications developed as a result of ingenuity and technical expertise. PeroxyChem LLC is based in Philadelphia, Pennsylvania.

Buy $200M